Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9576529 | 1.00 | MEN1 (0.48) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL18883361 | 0.86 | TSHR (0.33) | MEN1KMT2ATSHRMAPK1ALDH1A1 | |
| SCHEMBL7961214 | 0.86 | TSHR (0.33) | MEN1KMT2ATSHRMAPK1ALDH1A1 | |
| Triethylene Glycol SCHEMBL7770640 | 0.84 | MEN1 (0.61) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL19000738 | 0.82 | MEN1 (0.52) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL27650343 | 0.81 | MEN1 (0.46) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL1003042 | 0.80 | MEN1 (0.50) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL18346638 | 0.80 | MEN1 (0.50) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL1004293 | 0.80 | MEN1 (0.50) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL14370702 | 0.80 | MEN1 (0.50) | MEN1KMT2ATSHRMAPK1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9909053-B2 | Polymer compositions | CHEVRON U.S.A. INC. (US) | 2018-03-06 | — | — | US | claimed |
| US-9902895-B2 | Polymer compositions | CHEVRON U.S.A. INC. (US) | 2018-02-27 | — | — | US | claimed |
| US-9902894-B2 | Polymer compositions | CHEVRON U.S.A. INC. (US) | 2018-02-27 | — | — | US | claimed |
| US-9896617-B2 | Polymer compositions | CHEVRON U.S.A. INC. (US) | 2018-02-20 | — | — | US | claimed |
| EP-3212732-A1 | POLYMER COMPOSITIONS | Chevron U.S.A., Inc. (US) | 2017-09-06 | — | — | EP | claimed |
| WO-2016069937-A1 | POLYMER COMPOSITIONS | CHEVRON U.S.A. INC. (US) | 2016-05-06 | — | — | WO | claimed |
| US-20160122626-A1 | POLYMER COMPOSITIONS | CHEVRON U.S.A. INC. | 2016-05-05 | — | — | US | claimed |
| US-20160122622-A1 | POLYMER COMPOSITIONS | CHEVRON U.S.A. INC. | 2016-05-05 | — | — | US | claimed |
| US-20160122623-A1 | POLYMER COMPOSITIONS | CHEVRON U.S.A. INC. | 2016-05-05 | — | — | US | claimed |
| US-20160122624-A1 | POLYMER COMPOSITIONS | CHEVRON U.S.A. INC. | 2016-05-05 | — | — | US | claimed |
| EP-0686171-B1 | ETHER COSOLVENTS FOR RESIN FORMULATIONS | BP CHEM INT LTD (GB) | 1999-09-22 | — | — | EP | claimed |
| JP-H08507573-A | — | — | 1996-08-13 | — | — | JP | claimed |
| EP-0686171-A1 | ETHER COSOLVENTS FOR RESIN FORMULATIONS | BP Chemicals Limited (GB) | 1995-12-13 | — | — | EP | claimed |
| WO-1995017461-A1 | ETHER COSOLVENTS FOR RESIN FORMULATIONS | BP CHEMICALS LIMITED (GB) | 1995-06-29 | — | — | WO | claimed |
| US-12584062-B2 | Method for stimulating injection wells using reducing agents | JGS RESOURCES, LLC (US) | 2026-03-24 | — | — | US | disclosed |
| US-12312534-B2 | Treating fluid comprising hydrocarbons, water, and polymer | CHEVRON U.S.A. INC. (US) | 2025-05-27 | — | — | US | disclosed |
| US-12215276-B2 | Ph control in fluid treatment | CHEVRON U.S.A. INC. (US) | 2025-02-04 | — | — | US | disclosed |
| US-5753738-A | BRANCHED ALKOXY ETHOXYETHANOL COMPOUNDS; IMPROVED WATER SOLUBILITY | BP CHEMICALS LIMITED (GB) | 1998-05-19 | — | — | US | disclosed |
| EP-0686171-A1 | ETHER COSOLVENTS FOR RESIN FORMULATIONS | BP Chemicals Limited (GB) | 1995-12-13 | — | — | EP | disclosed |
| WO-1995017461-A1 | ETHER COSOLVENTS FOR RESIN FORMULATIONS | BP CHEMICALS LIMITED (GB) | 1995-06-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12584062-B2 | Method for stimulating injection wells using reducing agents | JAK2, SLC6A12, JAK3 | MEN1 2779/4885KMT2A 2228/4885TSHR 1262/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.